China National Accord Medicines Corporation Ltd. (200028.SZ) SHZ

Currency In HKD

AD

Valuation

Market Cap12.43B
Enterprise Value19.3B
P/E Ratio10.85
PEG Ratio0.11
Price/Sales Ratio0.17
Price/Book Ratio0.66
Enterprise/Revenue0.25
Enterprise/EBITDA7.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.02
Operating Margin0.02
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.06

Income Statement

Revenue73.29B
Revenue/Share120.75
Gross Profit6.36B
EBITDA3.14B
Net Income1.14B
Diluted EPS2.04

Balance Sheet

Total Cash5.96B
Total Cash/Share9.82
Total Debt11.99B
Total Debt/Equity0.62
Current Ratio1.59
Book Value Per Share36.64

Price History

52-Week Change3.67
52-Week High12.98
52-Week Low11.5
Moving Average 50 Days12.15
Moving Average 200 Days12.28

Statistics

Average Volume181,221
Shares Outstanding1.06B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.62
Trailing Annual Dividend Yield2.94
Payout Ratio0.58
Last Split Factor10:11
Last Split DateJune 26, 2026
AD